logo-loader
viewSilence Therapeutics PLC

Silence Therapeutics CEO Ali Mortazavi steps down

Mortazavi, who had been at the helm of Silence for six years, will be temporarily replaced by the firm’s chair, Annalisa Jenkins, until a permanent successor is appointed

office worker leaving office
Mortazavi has stepped down with immediate effect

Ali Mortazavi, the long-serving chief executive of Silence Therapeutics PLC (LON:SLN), is stepping down from his role with immediate effect.

Mortazavi, who had been at the helm of the RNA therapeutics specialist for six years, will be replaced temporarily by the company’s chair, Annalisa Jenkins, until a permanent successor is found.

WATCH: Silence Therapeutics 'in a hot space with few competitors'

“On behalf of the board I would like to thank Ali for his achievements and commitment to Silence over the past six years,” said Jenkins.

“Under his leadership Silence has built an experienced international executive team with significant RNAi expertise that has established a strong IP and technology platform in GalNAC-based siRNA.”

Silence shares rose 6.7% to 144p in mid-morning trade.

Quick facts: Silence Therapeutics PLC

Price: 440 GBX

AIM:SLN
Market: AIM
Market Cap: £3.45 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Silence Therapeutics PLC named herein, including the promotion by the Company of Silence Therapeutics PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Silence Therapeutics 'charging ahead with its key...

David Solomon, chief executive of Silence Therapeutics PLC (LON:SLN), updates on developments across their three key programmes - SLN 500, 124 and 360. Discussing the firm's current valuation, Solomon says ''there's a lot more steam in the engine''. ''I think that's what's exciting - we're...

3 weeks, 3 days ago

2 min read